lilly glp 1 injection FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Eli Lilly launches weight-loss drug
Description
Boost natural fullness and curb cravings with botanical metabolic support

Selected Oral Agents for Type 2 Diabetes - Januvia

Physician-formulated for GLP-1 users
One of the best parts of my job is being a Day 1 investor in companies like @Ro (776 co) led by CEOs like @ZReitano solving real problems for folks thru technology

Accessed October 21, 2025